SARS CoV 2 Infection Revealed with Type 2 Sinoatrial Block
Ellouadghiri A1, Seddiki K1, Damaane K1, Maghfour A1, Magramane A1, Ezzouine H1, Charra B1, Bennouna E2, Abouriche A2, Choukrani H2, El Moqri A 2, Abouradi S2
1COVID-19 Dedicated ICU, University hospital of Casablanca, Morocco
2COVID-19 Dedicated Cardiology team, University hospital of Casablanca, Morocco
*Corresponding author: Ellouadghiri A, COVID-19 Dedicated ICU, University hospital of Casablanca, Morocco.
Citation: Ellouadghiri A, Seddiki K, Damaane K, Maghfour A, Magramane A, et al. (2020) SARS CoV 2 Infection Revealed with Type 2 Sinoatrial Block. Annal Cas Rep Rev: ACRR-120.
Received Date: 14 May 2020; Accepted Date: 18 May 2020; Published Date: 26 May 2020
Journal Title:Annals of Case Reports & Reviews
COVID 19 (SARS-CoV-2 infection) was declared as a pandemic by the WHO on March 11th, 2020. Its mortality risk is correlated to its pulmonary complications and refractory hypoxemia. Although CoViD 19 can have a direct impact on the cardiovascular system, cardiovascular diseases history can either predispose or worsen the corona virus infection. An association with a sinoatrial block was rarely noted in previous studies. The authors of this article report a rare case of association of COVID-19 infection and sinoatrial block, emphasizing the difficulties of the pharmacological treatment.